XBiotech Inc. (XBIT)
US Markets · Healthcare · Biotechnology
$2.37
+0.00%
Closing price as of 2026-06-08 · Source: TEK2day Finance
Key Metrics
Market Cap
$74.4M
About XBiotech Inc.
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.